Cargando…
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders
Autoimmune demyelinating diseases—including multiple sclerosis, neuromyelitis optica spectrum disorder, anti-myelin oligodendrocyte glycoprotein-associated disease, acute disseminated encephalomyelitis, and glial fibrillary acidic protein (GFAP)-associated meningoencephalomyelitis—are a heterogeneou...
Autores principales: | Allegretta, Caterina, D’Amico, Emanuele, Manuti, Virginia, Avolio, Carlo, Conese, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998258/ https://www.ncbi.nlm.nih.gov/pubmed/35409188 http://dx.doi.org/10.3390/ijms23073829 |
Ejemplares similares
-
The Role of Extracellular Vesicles in Demyelination of the Central Nervous System
por: López-Guerrero, José Antonio, et al.
Publicado: (2020) -
MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study
por: Zanghì, Aurora, et al.
Publicado: (2023) -
Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells
por: Laselva, Onofrio, et al.
Publicado: (2021) -
Delivery of Therapeutic Agents to the Central Nervous System and the Promise of Extracellular Vesicles
por: René, Charlotte A., et al.
Publicado: (2021) -
Therapeutic Potential of Extracellular Vesicles for Demyelinating Diseases; Challenges and Opportunities
por: Osorio-Querejeta, Iñaki, et al.
Publicado: (2018)